LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 151

Search options

  1. Article ; Online: Spike-microstates correlate with interictal epileptogenic discharges: a marker for hidden epileptic activity.

    Rochas, Vincent / Gschwind, Markus / Nedeltchev, Krassen / Seeck, Margitta

    Brain communications

    2023  Volume 5, Issue 3, Page(s) fcad124

    Abstract: Objectively estimating disease severity and treatment success is a main problem in outpatient managing of epilepsy. Self-reported seizures diaries are well-known to underestimate the actual seizure count, and repeated EEGs might not show interictal ... ...

    Abstract Objectively estimating disease severity and treatment success is a main problem in outpatient managing of epilepsy. Self-reported seizures diaries are well-known to underestimate the actual seizure count, and repeated EEGs might not show interictal epileptiform discharges (IEDs), although patients suffer from seizures. In this prospective study, we investigate the potential of microstate analysis to monitor epilepsy patients independently of their IED count. From our databank of candidates for epilepsy surgery, we included 18 patients who underwent controlled resting EEG sessions (with eyes closed, 30 min), at around the same time of the day, during at least four days (range: 4-8 days; mean: 5). Nine patients with temporal foci, six with extratemporal foci, and three with generalized epilepsy were included. Each patient's IEDs were marked and the topographic voltage maps of the IED peaks were averaged, and an individual average spike topography (AST) was created. The AST was then backfitted to each timepoint of the whole EEG resulting in the Spike-Microstate (SMS). The presence of the SMS in the residual EEG outside of the short IEDs epochs was determined for each recording session in each patient and correlated with the occurrence of the IEDs across all recording session, as well as with the drug charge of each day. Overall, SMS was much more represented in the routine EEG than the IEDs: they were identified 262 times more often than IEDs. The SMS time coverage correlated significantly with the IED occurrence rate (rho = 0.56;
    Language English
    Publishing date 2023-04-18
    Publishing country England
    Document type Journal Article
    ISSN 2632-1297
    ISSN (online) 2632-1297
    DOI 10.1093/braincomms/fcad124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Tracking Multifocal Epilepsy With Automated Electric Source Imaging in a Patient With Triple-X Syndrome.

    Gschwind, Markus / Zima, Barbora / Nedeltchev, Krassen / van Mierlo, Pieter / Rüegg, Stephan

    Journal of clinical neurology (Seoul, Korea)

    2022  Volume 18, Issue 1, Page(s) 96–98

    Language English
    Publishing date 2022-01-12
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 2500489-X
    ISSN 2005-5013 ; 1738-6586
    ISSN (online) 2005-5013
    ISSN 1738-6586
    DOI 10.3988/jcn.2022.18.1.96
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Age and Stroke Severity Matter Most for Clinical Outcome in Acute Arteriosclerotic Tandem Lesions.

    Huber, Cyrill / Berberat, Jatta / Sassenburg, Renske / Pflugi, Stefanie / Anon, Javier / Diepers, Michael / Andereggen, Lukas / Kahles, Timo / Luft, Andreas R / Nedeltchev, Krassen / Remonda, Luca / Gruber, Philipp

    Journal of clinical medicine

    2024  Volume 13, Issue 8

    Abstract: ... ...

    Abstract Background
    Language English
    Publishing date 2024-04-17
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm13082315
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Critique of apixaban versus warfarin in patients with atrial fibrillation.

    Nedeltchev, Krassen

    Stroke

    2012  Volume 43, Issue 3, Page(s) 922–923

    MeSH term(s) Anticoagulants/therapeutic use ; Atrial Fibrillation/drug therapy ; Clinical Trials, Phase IV as Topic ; Fibrinolytic Agents/therapeutic use ; Humans ; Pyrazoles/therapeutic use ; Pyridones/therapeutic use ; Randomized Controlled Trials as Topic ; Stroke/prevention & control ; Treatment Outcome ; Warfarin/therapeutic use
    Chemical Substances Anticoagulants ; Fibrinolytic Agents ; Pyrazoles ; Pyridones ; apixaban (3Z9Y7UWC1J) ; Warfarin (5Q7ZVV76EI)
    Language English
    Publishing date 2012-03
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.111.640961
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Sekundärprävention des Schlaganfalls.

    Mulic, Smaila / Kahles, Timo / Nedeltchev, Krassen

    Therapeutische Umschau. Revue therapeutique

    2019  Volume 75, Issue 7, Page(s) 420–424

    Abstract: Secondary prevention of ischemic stroke: overview of updated guidelines Abstract. It is widely stated that stroke is one of the most common diseases and the leading cause of severe disability in adults. Secondary stroke prevention is based on drug ... ...

    Title translation Secondary prevention of ischemic stroke: overview of updated guidelines.
    Abstract Secondary prevention of ischemic stroke: overview of updated guidelines Abstract. It is widely stated that stroke is one of the most common diseases and the leading cause of severe disability in adults. Secondary stroke prevention is based on drug treatment, risk factor control as well as interventional procedures such as carotid artery revascularization or percutaneous device closure of a patent foramen ovale in cryptogenic stroke patients younger than 60 years.
    MeSH term(s) Brain Ischemia ; Foramen Ovale, Patent ; Humans ; Practice Guidelines as Topic ; Secondary Prevention ; Septal Occluder Device ; Stroke/prevention & control
    Language German
    Publishing date 2019-03-29
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 82044-1
    ISSN 1664-2864 ; 0040-5930
    ISSN (online) 1664-2864
    ISSN 0040-5930
    DOI 10.1024/0040-5930/a001018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Recognizing myorhythmia 4 months after stroke - A teaching video.

    Finkener, Sebastian / Piroth, Tobias / Högg, Magdalena / Rüegg, Stephan / Nedeltchev, Krassen / Bally, Julien F / Gschwind, Markus

    Clinical parkinsonism & related disorders

    2022  Volume 6, Page(s) 100141

    Abstract: In this case study with video and neurophysiology, we describe a rare case of hemimyorhythmia occurring 4 months after a stroke with bilateral affection of the thalamus and right superior cerebellar peduncle (Guillain-Mollaret-triangle). This case and ... ...

    Abstract In this case study with video and neurophysiology, we describe a rare case of hemimyorhythmia occurring 4 months after a stroke with bilateral affection of the thalamus and right superior cerebellar peduncle (Guillain-Mollaret-triangle). This case and especially the video with the clinical and EMG presentation of a synchronous rhythmic pattern at 3,1 Hz makes an important educational contribution to the recognition of myorhythmia and discussed differential diagnoses.
    Language English
    Publishing date 2022-03-14
    Publishing country England
    Document type Case Reports
    ISSN 2590-1125
    ISSN (online) 2590-1125
    DOI 10.1016/j.prdoa.2022.100141
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Bei akutem Hirnschlag Antihypertensiva meiden

    Nedeltchev, Krassen

    Hausarzt-Praxis

    2011  Volume 6, Issue 14, Page(s) 6

    Language German
    Document type Article
    ZDB-ID 2229849-6
    ISSN 1661-6197
    Database Current Contents Medicine

    More links

    Kategorien

  8. Article: SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot.

    Achtnichts, Lutz / Ovchinnikov, Arkady / Jakopp, Barbara / Oberle, Michael / Nedeltchev, Krassen / Fux, Christoph Andreas / Sellner, Johann / Findling, Oliver

    Vaccines

    2022  Volume 10, Issue 2

    Abstract: Evidence suggests limited development of protective IgG responses to mRNA-based vaccines in sphingosine-1-phosphate receptor (S1PR)-modulator treated individuals with multiple sclerosis (MS). We studied the extent of the humoral immune response after the ...

    Abstract Evidence suggests limited development of protective IgG responses to mRNA-based vaccines in sphingosine-1-phosphate receptor (S1PR)-modulator treated individuals with multiple sclerosis (MS). We studied the extent of the humoral immune response after the preferred third mRNA SARS-CoV-2 vaccine in S1PR-modulator treated people with MS (pwMS) and insufficient IgG responses after the standard immunization scheme. Eight pwMS that were treated with fingolimod received a third homologous SARS-CoV-2 mRNA vaccine dose, either the Moderna's mRNA-1273 or Pfizer-BioNTech's BNT162b2 vaccine. We quantified the serum levels of IgG antibodies against the receptor-binding domain of SARS-CoV-2 four weeks later. An antibody titer of 100 AU/mL or more was considered protective. After the third vaccination, we found clinically relevant IgG titers in four out of eight individuals (50%). We conclude that the humoral immune response may reach protective levels after the third preferred dose of the homologous SARS-CoV-2 mRNA vaccine. Vaccine shots in S1PR-modulator treated pwMS ahead of schedule may be a strategy to overcome insufficient humoral immune responses following the standard vaccination scheme.
    Language English
    Publishing date 2022-02-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines10020341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Sekundärprävention des Schlaganfalls

    Mulic, Smaila / Kahles, Timo / Nedeltchev, Krassen

    Therapeutische Umschau

    2018  Volume 75, Issue 7, Page(s) 420–424

    Abstract: Der Schlaganfall gehört zu den häufigsten Erkrankungen und ist die häufigste Ursache von bleibenden Behinderungen im Erwachsenenalter. ...

    Abstract Der Schlaganfall gehört zu den häufigsten Erkrankungen und ist die häufigste Ursache von bleibenden Behinderungen im Erwachsenenalter.
    Keywords Therapie ; Risikofaktoren-Optimierung
    Language German
    Document type Article
    ZDB-ID 82044-1
    ISSN 1664-2864 ; 0040-5930
    ISSN (online) 1664-2864
    ISSN 0040-5930
    Database bibnet.org

    Kategorien

  10. Article ; Online: SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod

    Lutz Achtnichts / Arkady Ovchinnikov / Barbara Jakopp / Michael Oberle / Krassen Nedeltchev / Christoph Andreas Fux / Johann Sellner / Oliver Findling

    Vaccines, Vol 10, Iss 341, p

    Protective Humoral Immune Responses May Develop after the Preferred Third Shot

    2022  Volume 341

    Abstract: Evidence suggests limited development of protective IgG responses to mRNA-based vaccines in sphingosine-1-phosphate receptor (S1PR)-modulator treated individuals with multiple sclerosis (MS). We studied the extent of the humoral immune response after the ...

    Abstract Evidence suggests limited development of protective IgG responses to mRNA-based vaccines in sphingosine-1-phosphate receptor (S1PR)-modulator treated individuals with multiple sclerosis (MS). We studied the extent of the humoral immune response after the preferred third mRNA SARS-CoV-2 vaccine in S1PR-modulator treated people with MS (pwMS) and insufficient IgG responses after the standard immunization scheme. Eight pwMS that were treated with fingolimod received a third homologous SARS-CoV-2 mRNA vaccine dose, either the Moderna’s mRNA-1273 or Pfizer-BioNTech’s BNT162b2 vaccine. We quantified the serum levels of IgG antibodies against the receptor-binding domain of SARS-CoV-2 four weeks later. An antibody titer of 100 AU/mL or more was considered protective. After the third vaccination, we found clinically relevant IgG titers in four out of eight individuals (50%). We conclude that the humoral immune response may reach protective levels after the third preferred dose of the homologous SARS-CoV-2 mRNA vaccine. Vaccine shots in S1PR-modulator treated pwMS ahead of schedule may be a strategy to overcome insufficient humoral immune responses following the standard vaccination scheme.
    Keywords SARS-CoV-2 ; S1PR-modulator ; fingolimod ; humoral immune response ; vaccination ; COVID-19 ; Medicine ; R
    Subject code 616
    Language English
    Publishing date 2022-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top